Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 14/20 | 0.46 |
| ▸ | CRBN | Q96SW2 | 14/20 | 0.46 |
| ▸ | IKZF2 | Q9UKS7 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.34 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.33 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23832693 | 0.89 | CRBN (0.48) | DDB1CRBNIKZF2IRAK4 | |
| SCHEMBL23807915 | 0.86 | CRBN (0.48) | DDB1CRBNIKZF2IRAK4OPRM1 | |
| SCHEMBL21996979 | 0.86 | CRBN (0.48) | DDB1CRBNIKZF2IRAK4OPRM1 | |
| SCHEMBL21996871 | 0.86 | CRBN (0.51) | DDB1CRBNIKZF2 | |
| SCHEMBL23842432 | 0.86 | DRD2 (0.43) | DDB1CRBNIRAK4 | |
| SCHEMBL23832614 | 0.86 | DRD2 (0.43) | DDB1CRBNIRAK4 | |
| SCHEMBL27058468 | 0.86 | DRD2 (0.43) | DDB1CRBNIRAK4 | |
| Hydrochloric Acid SCHEMBL21997496 | 0.85 | CRBN (0.50) | DDB1CRBNIKZF2 | |
| SCHEMBL21997604 | 0.84 | DDB1 (0.45) | DDB1CRBN | |
| SCHEMBL31281949 | 0.83 | DDB1 (0.56) | DDB1CRBNIKZF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4731309-A1 | KRAS PROTEOLYSIS TARGETING CHIMERAS | Paq Therapeutics Inc. (US) | 2026-04-29 | — | — | EP | disclosed |
| WO-2024263586-A1 | KRAS PROTEOLYSIS TARGETING CHIMERAS | PAQ Therapeutics Inc. (US) | 2024-12-26 | — | — | WO | disclosed |